Fluorescent guidance to surgical oncologists

Technology platform

FluoGuide's technology platform may be utilized in multiple ways, and one such way is by providing fluorescent visual guidance to surgeons conducting curative surgery. This application of FluoGuide's technology platform is currently being applied in clinical trials.

In essence, FluoGuide is able to combine molecules that target uPAR (urokinase-type plasminogen activator receptor), which is highly prevalent within and on the forefront of most kinds of solid cancers, and fluorophores (chemical compounds that can emit light under certain conditions). These novel compounds make up FluoGuide's pipeline.